Safety Data SheetChemical Risk Assessment

Levact

by Napp Pharmaceuticals

SDS · PDF, approx. 220 KB CRA · PDF, approx. 180 KB

Levact is supplied by Napp Pharmaceuticals under product code Levact ® 2.5 mg/ml. 26mg and 60mg Vials, Ribomustin ®. This page provides both the Safety Data Sheet (SDS) and the Chemical Risk Assessment (CRA) for this substance, under GHS/CLP regulations for UK workplace use under COSHH. The full SDS and CRA documents are available to download above.

This SDS was last revised on 1 October 2010. The matching CRA is updated in line with SDS revisions. Workplaces handling this substance should retain a current SDS and risk assessment for the duration of use.


Language
English
Regulation
GHS/CLP
Revision Date
01 Oct 2010
Signal Word
DANGER
Product Code
Levact ® 2.5 mg/ml. 26mg and 60mg Vials, Ribomustin ®
CAS Number
3543-75-7

Switch between the Safety Data Sheet and the Chemical Risk Assessment for this substance.

Hazards at a GlanceFrom the Safety Data Sheet
Signal Word: DANGER

Acute toxicityGHS06Acute toxicity
Health hazardGHS08Health hazard
Hazard Statements (H-phrases)
H301
Toxic if swallowed.
H351
Suspected of causing cancer.
H360
May damage fertility or the unborn child.

Need the full hazard breakdown? Precautionary statements, first aid, physical properties and exposure controls are in the full SDS PDF.


Common QuestionsAbout this Safety Data Sheet

Need help with Safety Data Sheets? You've come to the right place!

CONTACT US